Compendium of Cancer Genome Aberrations

Changes

GTS5:Volunteer Assignments and Opportunities (view source)

Revision as of 13:45, 25 February 2024

2,733 bytes removed ,  13:45, 25 February 2024
no edit summary
Line 6: Line 6:     
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
−
  −
<br />
  −
{| class="wikitable" style="margin:auto"
  −
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
  −
|-
  −
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
  −
!'''Date Assigned to Author'''
  −
!'''Target Completion Date'''
  −
!'''Author Content (Pending or Complete)'''
  −
!'''Date Completed by Author'''!!'''Associate Editor'''
  −
!'''Date of Last Editor Review'''
  −
!'''Notes'''
  −
|-
  −
|CHAPTER 2 (GROWTH FACTOR RECEPTORS AND RELATED SIGNALLING PATHWAYS)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|[[Neurofibromatosis Type 1 (NF1)]]
  −
|Disease
  −
|Ngoni Faya (trainee) + Madina Sukhanova
  −
|7/12/2023
  −
|
  −
|PENDING
  −
|
  −
|Madina Sukhanova (Madina S)
  −
|
  −
|Named based on GTS5 book
  −
|-
  −
|[[Familial Adenomatous Polyposis (APC)]]
  −
|Disease
  −
|Jennifer Laffin
  −
|8/20/2023
  −
|
  −
|PENDING
  −
|
  −
|MS / LS
  −
|
  −
|Named based on GTS5 book
  −
|-
  −
|[[Peutz-Jeghers Syndrome (STK11)]]
  −
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|[[Hereditary Gastric and Breast Cancer Syndrome (CDH1, CTNNA1)]]
  −
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|CHAPTER 3 (OXIDATIVE STRESS RESPONSE AND METABOLISM)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|CHAPTER 4 (CELL CYCLE AND APOPTOSIS PATHWAYS)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|[[Li-Fraumeni Syndrome (TP53)]]
  −
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|CHAPTER 5 (DNA REPAIR AND GENOMIC STABILITY)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|[[Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)]]||Disease||Jennie Thurston
  −
|7/2/2023
  −
|
  −
|PENDING
  −
|
  −
|LS
  −
|
  −
|Named based on GTS5 book
  −
|-
  −
|[[BRCA-Related Cancer Predisposition Syndrome (BRCA1, BRCA2)|''BRCA''-Related Cancer Predisposition Syndrome (''BRCA1'', ''BRCA2'')]]
  −
|Disease
  −
|Constance Albarracin / Katherine Geiersbach
  −
|
  −
|
  −
|PENDING
  −
|
  −
|Katherine Geiersbach
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|[[PALB2-Related Cancer Predisposition Syndrome (PALB2)]]
  −
|Disease
  −
|Constance Albarracin / Katherine Geiersbach / Jun Liao
  −
|
  −
|
  −
|PENDING
  −
|
  −
|Katherine Geiersbach
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|[[Ataxia-Telangiectasia Syndrome (ATM)]]
  −
|Disease
  −
|Evin Gulbahce / Katherine Geiersbach
  −
|
  −
|
  −
|PENDING
  −
|
  −
|Katherine Geiersbach
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|[[CHEK2-Related Hereditary (Breast) Cancer Predisposition Syndrome (CHEK2)]]
  −
|Disease
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|
  −
|Named based on GTS5 book (page created 12/30/23)
  −
|-
  −
|CHAPTER 6 (TELOMERE MAINTENANCE)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|CHAPTER 7 (EPIGENETIC DRIVERS AND CHROMATIN REMODELLING)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|CHAPTER 8 (RNA REGULATION)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|[[DICER1-Related Tumour Predisposition Syndrome (DICER1)]]
  −
|Disease
  −
|Jennie Thurston
  −
|7/2/2023
  −
|
  −
|PENDING
  −
|
  −
|LS
  −
|
  −
|Named based on GTS5 book
  −
|-
  −
|CHAPTER 9 (PROTEIN REGULATION)
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|
  −
----<br />
  −
|-
  −
|}
   
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
 
|+<big>WHO Classification of Genetic Tumour Syndromes (5th Edition) Content</big>
Line 420: Line 127:  
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
 
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]]
 
|Disease
 
|Disease
 +
|Ngoni Faya (trainee) + Madina Sukhanova
 +
|7/12/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Madina Sukhanova (Madina S)
 
|
 
|
−
|
+
|Named based on GTS5 book
−
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
 
|[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]]
Line 497: Line 204:  
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
 
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]]
 
|Disease
 
|Disease
 +
|Jennifer Laffin
 +
|8/20/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|MS / LS
 
|
 
|
−
|
+
|Named based on GTS5 book
−
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
 
|[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
Line 581: Line 288:  
|
 
|
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
 
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
Line 592: Line 299:  
|
 
|
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
 
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]]
Line 841: Line 548:  
|
 
|
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
 
|[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]]
Line 942: Line 649:  
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
 
|[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
 
|Disease
 
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
−
|
+
|Named based on GTS5 book
−
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
 
|[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
 
|Disease
 
|Disease
 +
|Constance Albarracin / Katherine Geiersbach
 
|
 
|
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
−
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
 
|[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]]
 
|Disease
 
|Disease
 +
|Constance Albarracin / Katherine Geiersbach / Jun Liao
 
|
 
|
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
−
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
 
|[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
Line 1,041: Line 748:  
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
 
|[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]]
 
|Disease
 
|Disease
 +
|Evin Gulbahce / Katherine Geiersbach
 
|
 
|
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
−
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
 
|[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
Line 1,059: Line 766:  
|
 
|
 
|
 
|
−
|
+
|Named based on GTS5 book (page created 12/30/23)
 
|-
 
|-
 
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
 
|[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]]
Line 1,321: Line 1,028:  
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
 
|[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]]
 
|Disease
 
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
−
|
+
|Named based on GTS5 book
−
|
  −
|
  −
|
  −
|
   
|-
 
|-
 
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
 
|[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
Retrieved from "https://content.ccga.io/index.php/Special:MobileDiff/14222...14235"